Current Drug Development Projects

SHOW RESULTS FILTERED BY:
SEARCH RESULTS
Title Disorder PI Investor Contacts Institution
Developing Non-Muscle Myosin II Inhibitors for Substance Use Relapse Stimulant use disorder Miller, Courtney Miller, Courtney Scripps Florida
Development of an Oral Analgesic for Neuropathic Pain Neuropathic Pain Buckpitt, Alan Buckpitt, Alan EicOsis, LLC
Development of Human 12/15-lioxygenase therapeutics for stroke Stroke van Leyen, Klaus van Leyen, Klaus Massachusetts General Hospital
Discovery of non-addictive KOR antagonists for migraine prophylaxis Migraine Jones, Robert van Orden, Lori Jean Blackthorn Therapeutics
Discovery/Development of GABA-A Α5 Positive Allosteric Modulators for Treatment of MCI Due to AD Alzheimer's Disease Rozenzweig-Lipson, Sharon Rozenzweig-Lipson, Sharon AgeneBio, INC.
Kv7.2/7.3 Activators for the Treatment of Epilepsy Disorders Epilepsy Disorders Bozik, Michael Bozik, Michael Knopp Biosciences LLC
Optimization of Soluble Gamma-secretase Modulators for the Treatment of Alzheimer Alzheimer's Disease Wagner, Steven Lee Medeiros, Nelson UC San Diego, Massachusetts General Hospital
Orexin Receptor Antagonists for Drug Addiction and Panic Disorder Drug Addiction Kenny, Paul J Kenny, Paul J. Eolas Therapeutics, Inc.
Small molecule drugs for treatment of dry age-related macular degeneration Age-Related Macular Degeneration Petrukhin, Konstantin Petrukhin, Konstantin Columbia University
The Development of Small Molecule Inhibitors for Gaucher Disease Type 3 Gaucher Disease Type 3 Shayman, James Shayman, James University of Michigan